Literature DB >> 21786460

Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD.

Jun Yong Choi, Jialun Zhou, Michelle Giles, Jennifer Broom, David J Templeton, Matthew G Law, Romanee Chaiwarith, Junko Tanuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21786460      PMCID： PMC3097092          DOI： 10.1097/qai.0b013e31820fffba

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  11 in total

1.  Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease.

Authors:  C Piketty; P Castiel; L Belec; D Batisse; A Si Mohamed; J Gilquin; G Gonzalez-Canali; D Jayle; M Karmochkine; L Weiss; J P Aboulker; M D Kazatchkine
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

2.  Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.

Authors:  David M Moore; Robert S Hogg; Benita Yip; Evan Wood; Mark Tyndall; Paula Braitstein; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2005-11-01       Impact factor: 3.731

3.  Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Authors:  S Grabar; V Le Moing; C Goujard; C Leport; M D Kazatchkine; D Costagliola; L Weiss
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

4.  Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.

Authors:  Amanda Mocroft; Peter Reiss; Jacek Gasiorowski; Bruno Ledergerber; Justyna Kowalska; Antonio Chiesi; Jose Gatell; Aza Rakhmanova; Margaret Johnson; Ole Kirk; Jens Lundgren
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

5.  Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.

Authors:  Ruimin Tan; Andrew O Westfall; James H Willig; Michael J Mugavero; Michael S Saag; Richard A Kaslow; Mirjam C Kempf
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

6.  Rates of combination antiretroviral treatment change in Australia, 1997-2000.

Authors: 
Journal:  HIV Med       Date:  2002-01       Impact factor: 3.180

7.  Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.

Authors:  Suely H Tuboi; Martin W G Brinkhof; Matthias Egger; Roslyn A Stone; Paula Braitstein; Denis Nash; Eduardo Sprinz; François Dabis; Lee H Harrison; Mauro Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

8.  Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.

Authors:  Kathleen Falster; Kathy Petoumenos; John Chuah; Anne Mijch; Brian Mulhall; Mark Kelly; David A Cooper
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

9.  Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.

Authors:  Suely Hiromi Tuboi; Antonio Guilherme Pacheco; Lee H Harrison; Roslyn A Stone; Margaret May; Martin W G Brinkhof; François Dabis; Matthias Egger; Denis Nash; David Bangsberg; Paula Braitstein; Constantin T Yiannoutsos; Robin Wood; Eduardo Sprinz; Mauro Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

10.  The TREAT Asia HIV Observational Database: baseline and retrospective data.

Authors:  Jialun Zhou; N Kumarasamy; Rossana Ditangco; Adeeba Kamarulzaman; Christopher K C Lee; Patrick C K Li; Nicholas I Paton; Praphan Phanuphak; Sanjay Pujari; Asda Vibhagool; Wing-Wai Wong; Fujie Zhang; John Chuah; Kevin R Frost; David A Cooper; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.771
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.